Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

Sea sponge drug could boost advanced breast cancer survival by five months

Sea sponge drug could boost advanced breast cancer survival by five months

Genomic sequencing more efficient in predicting breast cancer risk than previously thought

Genomic sequencing more efficient in predicting breast cancer risk than previously thought

New proposal for combined therapy proves effective against a notoriously resistant HER2 breast cancer subtype

New proposal for combined therapy proves effective against a notoriously resistant HER2 breast cancer subtype

The Ninth International Conference of Anticancer Research: Part three: Recent advances in haematopoietic and breast cancers

The Ninth International Conference of Anticancer Research: Part three: Recent advances in haematopoietic and...

The Ninth International Conference of Anticancer Research: Part two: HOX Genes and Cancer

The Ninth International Conference of Anticancer Research: Part two: HOX Genes and Cancer

ESMO 2014: PIK3CA mutations blunt benefit of anti-HER2 drugs in breast cancer

ESMO 2014: PIK3CA mutations blunt benefit of anti-HER2 drugs in breast cancer

ESMO 2014: Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer

ESMO 2014: Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive...

ESMO 2014: Sentinel node biopsy safe for pregnant women with cancer

ESMO 2014: Sentinel node biopsy safe for pregnant women with cancer

ESMO 2014: Access to breast cancer drug lacking in Eastern Europe

ESMO 2014: Access to breast cancer drug lacking in Eastern Europe

Skirt size increase linked to 33% greater postmenopausal breast cancer risk

Skirt size increase linked to 33% greater postmenopausal breast cancer risk

More from ecancer